title: Infective Endovascular Fibrin Sheath Vegetations—A New Cause of Bacteremia Detected by Transesophageal Echocardiogram.
abstract: OBJECTIVE
  A fibrin sheath is a circumferential sleeve of endothelium that forms around the surface of implanted central venous catheters and frequently remains intact within the lumen of the vein after removal of the catheters. We describe a new entity of infective endovascular fibrin sheath vegetations.
  
  
  METHODS
  Records of patients hospitalized and found to have echocardiographically identified infective endovascular fibrin sheath vegetations at our institution, Cedars Sinai Medical Center, from 2010 to 2014 were reviewed for clinical variables of interest. Collected data included medical history, physical examination findings, laboratory, microbiology, imaging, a prior history of presence of a central venous catheter, treatment, and outcomes.
  
  
  RESULTS
  Eleven patients (20-77 years old; 6 women, 5 men) were found by transesophageal echocardiogram to have fibrin sheaths. All of the infective endovascular fibrin sheath vegetations were identified by transesophageal echocardiography, while none were seen with transthoracic echocardiography. Eight of 11 patients were critically ill, septic, and admitted to the Intensive Care Unit. Six patients were intubated and required vasopressor therapy. All cases were treated with long-term antibiotics, 5 were treated with anticoagulation, and 2 were treated with mechanical thrombectomy. Mortality was 36%, with death ranging from 44 to 251 days after diagnosis. The 90-day hospital readmission rate was 55%.
  
  
  CONCLUSIONS
  Infective endovascular fibrin sheath vegetations are not seen with transthoracic echocardiogram. They may be overlooked and not seen by transesophageal echocardiogram unless the vena cava is adequately imaged. Moreover, fibrin sheath vegetations are associated with a high morbidity and mortality. They should be treated as a serious endovascular infection and managed with aggressive medical or interventional therapies, or both.
authors: The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif.
authors: Stephen
authors: S
authors: Tang
authors: The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif; The Heart Institute, Sheba Medical Center, Tel HaShomer, Israel; Sackler School of Medicine, Tel Aviv, Israel.
authors: Roy
authors: R
authors: Beigel
authors: The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif.
authors: Reza
authors: R
authors: Arsanjani
authors: Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, Calif.
authors: Brent
authors: B
authors: Larson
authors: Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, Calif.
authors: Daniel
authors: D
authors: Luthringer
authors: The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif. Electronic address: Robert.siegel@cshs.org.
authors: Robert
authors: R
authors: Siegel
mesh_terms: D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000000981:diagnostic imaging* / Q000209:etiology*; D055499:Catheter-Related Infections / Q000000981:diagnostic imaging*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D062905:Central Venous Catheters / Q000009:adverse effects* / Q000382:microbiology*; D017548:Echocardiography, Transesophageal; D005260:Female; D005549:Foreign-Body Reaction / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged
keywords: Central venous catheter; Endocarditis; Endovascular infection; Fibrin sheath; Transesophageal echocardiogram